A 70-year-old man with metastatic castration-resistant prostate cancer presents to the emergency department with severe back pain, bilateral lower extremity weakness (3/5 strength), and urinary retention that started 8 hours ago. He has known bone metastases and his PSA has been rising despite androgen deprivation therapy. MRI spine shows an epidural mass at T10 with severe spinal cord compression and near-complete canal obliteration. He is neurologically intact above T10. Radiation oncology, neurosurgery, and medical oncology are consulted. Evaluate the optimal management approach.
Q2
A 3-year-old boy is brought to the clinic for evaluation of an undescended left testicle noted since birth. The right testicle is in normal scrotal position. On examination, the left testicle is palpable in the inguinal canal and can be manipulated to the upper scrotum but retracts immediately upon release. The testicle appears smaller than the contralateral side. The parents report they were told to wait and see if it descends spontaneously. What is the most appropriate management at this time?
Q3
A 58-year-old man with a 15-pack-year smoking history undergoes radical cystectomy with ileal conduit urinary diversion for muscle-invasive bladder cancer. Final pathology shows pT3N1 disease with 3 of 18 lymph nodes positive for metastatic urothelial carcinoma, with negative surgical margins. His postoperative recovery is uncomplicated. The oncology team recommends adjuvant chemotherapy, but the patient has baseline chronic kidney disease with creatinine 2.0 mg/dL and GFR 35 mL/min/1.73m². Evaluate the optimal management strategy.
Q4
A 65-year-old man with benign prostatic hyperplasia (BPH) presents with acute urinary retention. A Foley catheter is placed, draining 1200 mL of clear urine. Over the next 6 hours, he produces 800 mL/hour of urine and becomes hypotensive with BP 85/50 mmHg. Laboratory studies show sodium 148 mEq/L, potassium 3.2 mEq/L, and creatinine 2.1 mg/dL (baseline 1.0 mg/dL). What is the underlying pathophysiologic mechanism and appropriate management priority?
Q5
A 28-year-old man presents with a painless right testicular mass discovered on self-examination. Ultrasound shows a 2.5 cm heterogeneous intratesticular mass. Tumor markers show AFP 450 ng/mL (normal <10), beta-hCG 25 mIU/mL (normal <5), and normal LDH. CT chest/abdomen/pelvis reveals a 3 cm retroperitoneal lymph node mass and multiple small pulmonary nodules. He undergoes radical inguinal orchiectomy, with pathology showing mixed germ cell tumor with elements of embryonal carcinoma and yolk sac tumor. What is the most appropriate next step?
Q6
A 45-year-old man presents with acute onset of severe right scrotal pain and swelling for 4 hours. He denies trauma or urinary symptoms. On examination, the right testicle is high-riding, swollen, and exquisitely tender. The cremasteric reflex is absent on the right. Doppler ultrasound shows absent arterial flow to the right testicle. He is taken emergently to the operating room. During scrotal exploration, the right testicle appears dusky but shows some capillary refill after detorsion. What is the most appropriate intraoperative management?
Q7
A 2-day-old male neonate is evaluated for bilateral flank masses palpable on physical examination. Prenatal ultrasound had shown bilateral enlarged kidneys with increased echogenicity and poor corticomedullary differentiation. The infant has Potter facies, pulmonary hypoplasia requiring mechanical ventilation, and oligohydramnios was noted during pregnancy. Postnatal ultrasound confirms bilateral enlarged kidneys with multiple small cysts throughout both kidneys. Serum creatinine is 3.2 mg/dL. What is the underlying diagnosis?
Q8
A 55-year-old man undergoes a routine health screening. Digital rectal examination reveals a firm, irregular nodule in the right lobe of the prostate. PSA level is 8.5 ng/mL. He has no urinary symptoms and is otherwise healthy. A 12-core transrectal ultrasound-guided prostate biopsy is performed, showing Gleason 3+4=7 adenocarcinoma in 3 of 12 cores with <50% involvement. Bone scan and CT abdomen/pelvis are negative for metastases. What is the most appropriate management?
Q9
A 72-year-old man with a history of smoking presents with painless gross hematuria for 2 weeks. Physical examination is unremarkable. Urinalysis confirms hematuria with no signs of infection. Cystoscopy reveals a 3 cm papillary tumor on the lateral bladder wall. Transurethral resection of bladder tumor (TURBT) pathology shows high-grade urothelial carcinoma invading the lamina propria but not the muscularis propria. What is the most appropriate next step in management?
Q10
A 68-year-old man presents to the emergency department with sudden onset of severe left flank pain radiating to the groin, along with nausea and hematuria. Vital signs show BP 150/90 mmHg, HR 105 bpm, temperature 37.2°C. Urinalysis reveals 50-100 RBCs/hpf. Non-contrast CT scan shows a 7 mm stone in the left ureterovesical junction with moderate hydronephrosis. Creatinine is 1.1 mg/dL. What is the most appropriate initial management?
Urology Basics US Medical PG Practice Questions and MCQs
Question 1: A 70-year-old man with metastatic castration-resistant prostate cancer presents to the emergency department with severe back pain, bilateral lower extremity weakness (3/5 strength), and urinary retention that started 8 hours ago. He has known bone metastases and his PSA has been rising despite androgen deprivation therapy. MRI spine shows an epidural mass at T10 with severe spinal cord compression and near-complete canal obliteration. He is neurologically intact above T10. Radiation oncology, neurosurgery, and medical oncology are consulted. Evaluate the optimal management approach.
A. Corticosteroids, radiation therapy, and switch to next-line systemic therapy
B. Stereotactic radiosurgery as single-modality treatment
C. Emergent surgical decompression followed by radiation therapy (Correct Answer)
D. Palliative care consultation and comfort measures only given metastatic disease
E. High-dose corticosteroids and emergent radiation therapy alone
Explanation: ***Emergent surgical decompression followed by radiation therapy***
- For patients with **malignant spinal cord compression (MSCC)** and acute neurologic deficits lasting <48 hours, **decompressive surgery** followed by radiotherapy results in better ambulatory outcomes than radiation alone.
- This patient has a **single level of compression** (T10) and a reasonable functional status above the lesion, making him an ideal candidate for surgery to preserve **quality of life**.
*Corticosteroids, radiation therapy, and switch to next-line systemic therapy*
- While **systemic therapy** is important for managing metastatic disease, it does not address the acute **mechanical compression** currently threatening spinal cord viability.
- Postponing definitive mechanical decompression in favor of systemic treatment would likely result in **permanent paraplegia** given the severe canal obliteration.
*Stereotactic radiosurgery as single-modality treatment*
- **Stereotactic radiosurgery (SRS)** is effective for spinal metastases but is generally not the primary choice when there is **high-grade spinal cord compression** with an associated neurologic deficit.
- Surgery is needed first to provide immediate **mechanical decompression** and create a "separation" distance between the cord and the tumor for safer high-dose radiation.
*Palliative care consultation and comfort measures only given metastatic disease*
- Although the cancer is metastatic, preserving **ambulatory function** and bladder control is a priority for maintaining dignity and independence.
- **MSCC** is an oncologic emergency where intervention is indicated unless the patient's **life expectancy** is very short (typically <3 months), which is not clearly the case here.
*High-dose corticosteroids and emergent radiation therapy alone*
- Radiation therapy alone is typically reserved for patients who are not **surgical candidates**, have multisegmental disease, or have complete paralysis for >48 hours.
- **Direct decompressive surgery** is superior for restoring and maintaining the ability to walk in patients with acute, unstable neurologic symptoms from a **single-level mass**.
Question 2: A 3-year-old boy is brought to the clinic for evaluation of an undescended left testicle noted since birth. The right testicle is in normal scrotal position. On examination, the left testicle is palpable in the inguinal canal and can be manipulated to the upper scrotum but retracts immediately upon release. The testicle appears smaller than the contralateral side. The parents report they were told to wait and see if it descends spontaneously. What is the most appropriate management at this time?
A. Immediate orchiopexy given the patient's age (Correct Answer)
B. Reassurance and follow-up at age 5 years before school entry
C. Continue observation as the testicle is palpable and may still descend
D. Orchiectomy given the size discrepancy and malignancy risk
E. Hormonal therapy with hCG to stimulate testicular descent
Explanation: ***Immediate orchiopexy given the patient's age***
- Spontaneous descent is highly unlikely after **6 months of age**; surgery is recommended as early as possible after this window to improve **fertility** and facilitate **cancer screening**.
- This patient is **3 years old**, which is well past the recommended management window of **6 to 18 months**, necessitating prompt surgical intervention.
*Continue observation as the testicle is palpable and may still descend*
- Spontaneous descent of a cryptorchid testis rarely occurs after **age 6 months**, making ongoing observation clinically inappropriate.
- Delayed treatment increases the risk of **testicular atrophy**, **germ cell loss**, and potentially **malignant transformation**.
*Hormonal therapy with hCG to stimulate testicular descent*
- **Hormonal therapy** (e.g., hCG or GnRH) is generally not recommended in the US due to poor **long-term efficacy** compared to surgery.
- The success rate of hormonal therapy is notably low for truly **cryptorchid** testes and does not replace the gold standard of **orchiopexy**.
*Reassurance and follow-up at age 5 years before school entry*
- Waiting until age 5 is inappropriate as it significantly increases the risk of **infertility** and **testicular germ cell tumors**.
- The diagnosis of a **retractile testis** (which might be observed) is ruled out here because the testis **retracts immediately** and is smaller than the contralateral side.
*Orchiectomy given the size discrepancy and malignancy risk*
- **Orchiectomy** (removal) is generally reserved for **post-pubertal males** or instances where the testis is found to be **non-viable** or severely dysgenetic during surgery.
- In a **3-year-old**, the primary goal is **orchiopexy** to preserve hormonal function and provide a chance for future fertility.
Question 3: A 58-year-old man with a 15-pack-year smoking history undergoes radical cystectomy with ileal conduit urinary diversion for muscle-invasive bladder cancer. Final pathology shows pT3N1 disease with 3 of 18 lymph nodes positive for metastatic urothelial carcinoma, with negative surgical margins. His postoperative recovery is uncomplicated. The oncology team recommends adjuvant chemotherapy, but the patient has baseline chronic kidney disease with creatinine 2.0 mg/dL and GFR 35 mL/min/1.73m². Evaluate the optimal management strategy.
A. Clinical trial enrollment or gemcitabine-based regimen with close monitoring (Correct Answer)
B. Immunotherapy with checkpoint inhibitor as adjuvant treatment
C. Standard cisplatin-based adjuvant chemotherapy despite renal function
D. Surveillance only given contraindication to effective chemotherapy
E. Carboplatin-based chemotherapy as substitute for cisplatin
Explanation: ***Clinical trial enrollment or gemcitabine-based regimen with close monitoring***
- In patients with **node-positive disease (pN1)** and **renal impairment**, enrolling in a clinical trial is a preferred strategy to explore novel therapies.
- While **cisplatin** is the gold standard, alternative regimens like **gemcitabine** combinations may be considered if dose modifications allow, though efficacy in the adjuvant setting is less robust.
*Immunotherapy with checkpoint inhibitor as adjuvant treatment*
- Adjuvant **immunotherapy** (e.g., Nivolumab) is an emerging option for high-risk patients, but traditionally it is reserved for those who cannot tolerate or refuse chemotherapy.
- At the time of standard board-level recommendations, it is often prioritized after failure or contraindication to **platinum-based** therapy rather than as the primary recommendation over clinical trials.
*Standard cisplatin-based adjuvant chemotherapy despite renal function*
- **Cisplatin** is strictly contraindicated in patients with a **GFR < 60 mL/min** due to its high risk of severe **nephrotoxicity**.
- Administering standard doses to this patient with a **GFR of 35 mL/min** could lead to permanent **renal failure** and life-threatening toxicity.
*Surveillance only given contraindication to effective chemotherapy*
- **Surveillance** is inappropriate for **pT3N1 disease** because the risk of systemic recurrence is extremely high without adjuvant intervention.
- Even with **renal comorbidities**, some form of systemic management or trial participation is preferred over a purely passive approach.
*Carboplatin-based chemotherapy as substitute for cisplatin*
- **Carboplatin** is notably inferior to **cisplatin** in achieving durable responses for **urothelial carcinoma**.
- While often used in the metastatic setting for "cisplatin-ineligible" patients, its benefit as a standard **adjuvant** treatment for muscle-invasive disease is not well-established.
Question 4: A 65-year-old man with benign prostatic hyperplasia (BPH) presents with acute urinary retention. A Foley catheter is placed, draining 1200 mL of clear urine. Over the next 6 hours, he produces 800 mL/hour of urine and becomes hypotensive with BP 85/50 mmHg. Laboratory studies show sodium 148 mEq/L, potassium 3.2 mEq/L, and creatinine 2.1 mg/dL (baseline 1.0 mg/dL). What is the underlying pathophysiologic mechanism and appropriate management priority?
A. Acute tubular necrosis from obstruction; initiate dialysis preparation
B. Sepsis from urinary tract infection; broad-spectrum antibiotics and vasopressors
C. Prerenal azotemia from volume depletion; aggressive IV fluid resuscitation with normal saline
D. SIADH from bladder distension; fluid restriction
E. Post-obstructive diuresis with sodium and water loss; careful fluid replacement matching urine output (Correct Answer)
Explanation: ***Post-obstructive diuresis with sodium and water loss; careful fluid replacement matching urine output***
- Relief of severe **bladder outlet obstruction** causes a massive **osmotic diuresis** due to retained solutes (urea, sodium) and medullary washout, leads to potential **hypovolemic shock**.
- Management involves replacing **half of the urine output** with hypotonic fluids (e.g., **0.45% saline**) to maintain perfusion while allowing the body to correct the fluid-overload state.
*Acute tubular necrosis from obstruction; initiate dialysis preparation*
- While **creatinine elevation** suggests AKI, the primary issue here is the massive **volume loss** and hypotension following catheterization, rather than intrinsic renal failure.
- **Dialysis** is not indicated as the first step for post-obstructive AKI when the obstruction has been relieved and urine output is high.
*Sepsis from urinary tract infection; broad-spectrum antibiotics and vasopressors*
- Although **hypotension** occurs, the timeline immediately following drainage and the high-volume urine output points to **physiologic diuresis** rather than infectious shock.
- There is no mention of **fever**, leukocytosis, or cloudy urine to prioritize **sepsis** over post-obstructive diuresis.
*Prerenal azotemia from volume depletion; aggressive IV fluid resuscitation with normal saline*
- **Prerenal azotemia** usually presents with **oliguria**, not massive polyuria of 800 mL/hour; aggressive NS may worsen **hypernatremia** (148 mEq/L).
- **Aggressive resuscitation** with isotonic saline can stimulate further diuresis and fails to address the specific electrolyte needs of post-obstructive patients.
*SIADH from bladder distension; fluid restriction*
- **SIADH** results in water retention and **hyponatremia**, which contradicts this patient's high urine output and **hypernatremia** (148 mEq/L).
- **Fluid restriction** would be dangerous in a patient who is already **hypotensive** and losing 800 mL of fluid per hour.
Question 5: A 28-year-old man presents with a painless right testicular mass discovered on self-examination. Ultrasound shows a 2.5 cm heterogeneous intratesticular mass. Tumor markers show AFP 450 ng/mL (normal <10), beta-hCG 25 mIU/mL (normal <5), and normal LDH. CT chest/abdomen/pelvis reveals a 3 cm retroperitoneal lymph node mass and multiple small pulmonary nodules. He undergoes radical inguinal orchiectomy, with pathology showing mixed germ cell tumor with elements of embryonal carcinoma and yolk sac tumor. What is the most appropriate next step?
A. Combination chemotherapy with BEP regimen (Correct Answer)
B. Adjuvant single-agent carboplatin
C. Surveillance with serial tumor markers and imaging
D. Radiation therapy to retroperitoneum
E. Retroperitoneal lymph node dissection (RPLND)
Explanation: ***Combination chemotherapy with BEP regimen***
- This patient has **Stage III non-seminomatous germ cell tumor (NSGCT)**, characterized by visceral lung metastases and elevated **Alpha-Fetoprotein (AFP)**, requiring systemic treatment with **Bleomycin, Etoposide, and Cisplatin (BEP)**.
- According to the **IGCCCG criteria**, the presence of pulmonary nodules and retroperitoneal masses indicates metastatic disease where chemotherapy is the gold standard for achieving cure.
*Adjuvant single-agent carboplatin*
- This treatment is specifically used for **Stage I seminoma** to reduce the risk of recurrence and is not effective for **NSGCT** or metastatic disease.
- **Mixed germ cell tumors** containing elements like **yolk sac tumor** (which secretes AFP) are inherently resistant to traditional radiotherapy and single-agent platinum protocols used in seminomas.
*Surveillance with serial tumor markers and imaging*
- Surveillance is an option only for **Stage I** patients (disease confined to the testis) who have a low risk of recurrence and normal post-orchiectomy markers.
- Choosing surveillance in the setting of **gross metastatic disease** (pulmonary nodules and 3 cm lymph nodes) would lead to rapid disease progression and poor outcomes.
*Radiation therapy to retroperitoneum*
- **NSGCTs** are considered **radioresistant**, unlike pure seminomas which are highly radiosensitive.
- Radiation therapy has no role in the primary management of metastatic **embryonal carcinoma** or **yolk sac tumor** because it does not address systemic (lung) involvement.
*Retroperitoneal lymph node dissection (RPLND)*
- **RPLND** is primarily indicated for Stage I or II NSGCT with small-volume nodal disease; however, in Stage III with **distant metastases**, chemotherapy must come first.
- In the setting of pulmonary nodules, surgical removal of abdominal nodes alone is insufficient; surgery is typically reserved for **residual masses** larger than 1 cm after completion of chemotherapy.
Question 6: A 45-year-old man presents with acute onset of severe right scrotal pain and swelling for 4 hours. He denies trauma or urinary symptoms. On examination, the right testicle is high-riding, swollen, and exquisitely tender. The cremasteric reflex is absent on the right. Doppler ultrasound shows absent arterial flow to the right testicle. He is taken emergently to the operating room. During scrotal exploration, the right testicle appears dusky but shows some capillary refill after detorsion. What is the most appropriate intraoperative management?
A. Detorsion, right orchiectomy, and left orchiopexy
B. Detorsion, warm compress application, and delayed reassessment
C. Immediate right orchiectomy without detorsion attempt
D. Detorsion and right orchiopexy only
E. Detorsion, observation for viability, and bilateral orchiopexy (Correct Answer)
Explanation: ***Detorsion, observation for viability, and bilateral orchiopexy***
- The presence of **capillary refill** after detorsion indicates that the testicle is potentially viable and should be preserved rather than removed.
- **Bilateral orchiopexy** is mandatory because the underlying anatomic defect (**bell-clapper deformity**) is usually bilateral, putting the contralateral testis at high risk for future torsion.
*Detorsion, right orchiectomy, and left orchiopexy*
- **Orchiectomy** is inappropriate here because the testicle shows signs of viability (capillary refill) and should not be removed unless it is clearly **necrotic**.
- While the left side must be fixed, the right testicle should be saved and secured with **orchiopexy** if it is not dead.
*Detorsion, warm compress application, and delayed reassessment*
- While warm compresses are used intraoperatively to encourage perfusion, **delayed reassessment** outside of the initial surgery is not standard; viability is determined in the OR.
- This option fails to mention the critical step of performing **bilateral orchiopexy** to prevent recurrence on both sides.
*Immediate right orchiectomy without detorsion attempt*
- It is standard surgical practice to attempt **detorsion** and observe for reperfusion before committing to an **orchiectomy**.
- Removing a testicle that might be salvaged (as indicated by the dusky but reperfusing appearance) is a major surgical error.
*Detorsion and right orchiopexy only*
- Performing a **unilateral orchiopexy** is insufficient because the contralateral testis remains at risk for torsion due to the bilateral nature of the **tunica vaginalis** abnormality.
- Standards of care require fixing the **asymptomatic side** during the same surgical procedure to ensure future fertility and hormonal health.
Question 7: A 2-day-old male neonate is evaluated for bilateral flank masses palpable on physical examination. Prenatal ultrasound had shown bilateral enlarged kidneys with increased echogenicity and poor corticomedullary differentiation. The infant has Potter facies, pulmonary hypoplasia requiring mechanical ventilation, and oligohydramnios was noted during pregnancy. Postnatal ultrasound confirms bilateral enlarged kidneys with multiple small cysts throughout both kidneys. Serum creatinine is 3.2 mg/dL. What is the underlying diagnosis?
A. Multicystic dysplastic kidney (MCDK)
B. Posterior urethral valves
C. Autosomal dominant polycystic kidney disease (ADPKD)
D. Bilateral Wilms tumor
E. Autosomal recessive polycystic kidney disease (ARPKD) (Correct Answer)
Explanation: ***Autosomal recessive polycystic kidney disease (ARPKD)***
- Characterized by **bilateral enlarged kidneys** with multiple tiny cysts representing dilated **collecting ducts**, often leading to **oligohydramnios** and **Potter sequence** (pulmonary hypoplasia, facies).
- Typically presents in the **neonatal period** with renal failure and palpable flank masses; it is strongly associated with **congenital hepatic fibrosis**.
*Multicystic dysplastic kidney (MCDK)*
- This condition is usually **unilateral** and results from abnormal ureteric bud-metanephric blastema interaction; it does not typically cause the **Potter sequence** unless bilateral.
- Ultrasound would show large, non-communicating cysts with an **absence of normal renal parenchyma**, unlike the diffuse tiny cysts seen in ARPKD.
*Posterior urethral valves*
- The most common cause of bladder outlet obstruction in male infants, typically presenting with **bilateral hydroureter** and **hydronephrosis** rather than multiple parenchymal cysts.
- Ultrasound would demonstrate a **thick-walled bladder** and a dilated posterior urethra (keyhole sign), which are absent in this scenario.
*Autosomal dominant polycystic kidney disease (ADPKD)*
- Primarily an **adulthood** diagnosis; while rare neonatal forms exist, they do not typically present with the uniform **microcystic** appearance and severe **pulmonary hypoplasia** seen here.
- Usually associated with a **family history** of early-onset hypertension or renal failure in a parent, and cysts are often larger and more macro-structural.
*Bilateral Wilms tumor*
- Presents as **solid abdominal masses** rather than diffuse cystic enlargement; it is the most common renal malignancy in children but rarely presents at birth.
- It is not associated with **oligohydramnios** or the **Potter sequence**, as renal function is typically preserved until the tumors are very large.
Question 8: A 55-year-old man undergoes a routine health screening. Digital rectal examination reveals a firm, irregular nodule in the right lobe of the prostate. PSA level is 8.5 ng/mL. He has no urinary symptoms and is otherwise healthy. A 12-core transrectal ultrasound-guided prostate biopsy is performed, showing Gleason 3+4=7 adenocarcinoma in 3 of 12 cores with <50% involvement. Bone scan and CT abdomen/pelvis are negative for metastases. What is the most appropriate management?
A. Androgen deprivation therapy alone
B. Watchful waiting with symptom management
C. Active surveillance with serial PSA and repeat biopsy
D. Transurethral resection of the prostate
E. Radical prostatectomy or definitive radiation therapy (Correct Answer)
Explanation: ***Radical prostatectomy or definitive radiation therapy***
- This patient falls into the **intermediate-risk category** due to a **Gleason score of 7 (3+4)** and a **PSA between 10-20 ng/mL** (or in this case, a Gleason 7 with PSA 8.5).
- Definitive treatment with curative intent, such as **radical prostatectomy** or **radiation therapy**, is indicated for localized prostate cancer in patients with a **life expectancy >10 years**.
*Androgen deprivation therapy alone*
- **ADT** is primarily used as **palliative therapy** for metastatic disease or as an adjunct to radiation in high-risk localized cases.
- It is not recommended as **monotherapy** for localized, curable prostate cancer in a healthy 55-year-old.
*Watchful waiting with symptom management*
- This approach is reserved for patients with a **limited life expectancy** (<10 years) where the goal is to manage symptoms rather than provide a cure.
- At age 55, this patient has a significant life expectancy, making **curative intervention** more appropriate than passive observation.
*Active surveillance with serial PSA and repeat biopsy*
- **Active surveillance** is the preferred strategy for **low-risk** (Gleason ≤6, PSA <10) or very-low-risk prostate cancer.
- Because this patient has **intermediate-risk disease** (Gleason 7), the risk of progression is higher, usually necessitating active treatment.
*Transurethral resection of the prostate*
- **TURP** is a procedure used to relieve **bladder outlet obstruction** symptoms caused by benign prostatic hyperplasia (BPH).
- It is not a treatment for **prostate adenocarcinoma** and does not address the malignant cells located in the peripheral zone of the gland.
Question 9: A 72-year-old man with a history of smoking presents with painless gross hematuria for 2 weeks. Physical examination is unremarkable. Urinalysis confirms hematuria with no signs of infection. Cystoscopy reveals a 3 cm papillary tumor on the lateral bladder wall. Transurethral resection of bladder tumor (TURBT) pathology shows high-grade urothelial carcinoma invading the lamina propria but not the muscularis propria. What is the most appropriate next step in management?
A. Surveillance cystoscopy in 3 months
B. Systemic chemotherapy with cisplatin
C. Radical cystectomy with urinary diversion
D. External beam radiation therapy
E. Intravesical BCG therapy (Correct Answer)
Explanation: ***Intravesical BCG therapy***
- This patient has **Non-Muscle Invasive Bladder Cancer (NMIBC)**, specifically stage **T1** (invasion of lamina propria) and **high-grade**, which carries a high risk of recurrence and progression.
- **Intravesical BCG** (Bacillus Calmette-Guérin) is the standard treatment after **TURBT** for high-risk NMIBC to induce an immune response that destroys residual malignant cells.
*Surveillance cystoscopy in 3 months*
- **Surveillance alone** is insufficient for T1 high-grade tumors due to the very high risk of progression to **muscle-invasive disease**.
- While cystoscopy is part of follow-up, it must be preceded by adjuvant therapy like **BCG induction** in high-risk patients.
*Systemic chemotherapy with cisplatin*
- **Systemic chemotherapy** is primary management for **metastatic** bladder cancer or as neoadjuvant therapy for **muscle-invasive** (T2+) disease.
- For disease localized to the **lamina propria**, intravesical (local) therapy is preferred over the toxicity of systemic drugs.
*Radical cystectomy with urinary diversion*
- **Radical cystectomy** is the gold standard for **Muscle-Invasive Bladder Cancer (MIBC)**, where the tumor involves the **muscularis propria** (T2).
- It is not the first-line step for a first-time T1 diagnosis unless the cancer is **BCG-refractory** or has very high-risk features like lymphovascular invasion.
*External beam radiation therapy*
- **Radiation therapy** is generally reserved for **bladder-sparing protocols** in muscle-invasive disease or for **palliative care** in advanced stages.
- It is not a standard primary treatment for **non-muscle invasive** high-grade urothelial carcinoma.
Question 10: A 68-year-old man presents to the emergency department with sudden onset of severe left flank pain radiating to the groin, along with nausea and hematuria. Vital signs show BP 150/90 mmHg, HR 105 bpm, temperature 37.2°C. Urinalysis reveals 50-100 RBCs/hpf. Non-contrast CT scan shows a 7 mm stone in the left ureterovesical junction with moderate hydronephrosis. Creatinine is 1.1 mg/dL. What is the most appropriate initial management?
A. Extracorporeal shock wave lithotripsy (ESWL)
B. Open ureterolithotomy
C. Immediate ureteroscopy with stone extraction
D. Emergent percutaneous nephrostomy
E. Medical expulsive therapy with alpha-blocker and analgesics (Correct Answer)
Explanation: ***Medical expulsive therapy with alpha-blocker and analgesics***
- For stones **less than 10 mm** in a stable patient without signs of infection or renal failure, **alpha-blockers** (like Tamsulosin) facilitate spontaneous passage by relaxing ureteral smooth muscle.
- The location at the **ureterovesical junction** and the manageable size of **7 mm** make medical management the most appropriate first-line strategy.
*Extracorporeal shock wave lithotripsy (ESWL)*
- **ESWL** is generally less effective for stones located deep in the pelvis or at the **distal ureter** due to difficulty in targeting and bony interference.
- It is not indicated as the *initial* step when the patient is stable and a trial of **spontaneous passage** is viable.
*Open ureterolithotomy*
- This is an **invasive surgical procedure** reserved only for complex cases where minimally invasive methods like **ureteroscopy** or ESWL have failed.
- It is never the first-line treatment for a simple **7 mm ureteral stone**.
*Immediate ureteroscopy with stone extraction*
- While effective for **distal stones**, immediate surgical intervention is typically reserved for patients with **uncontrolled pain**, stone size >10 mm, or failure of medical therapy.
- Conservative management is preferred initially if the patient is **systemically well** and the stone has a high chance of passing.
*Emergent percutaneous nephrostomy*
- This procedure is indicated for **decompression of an infected obstructed system** (urosepsis) or in cases of acute renal failure (e.g., bilateral obstruction or solitary kidney).
- This patient is **afebrile** with a normal **creatinine**, so emergent decompression is not required.
